By Robert Preidt HealthDay Reporter THURSDAY, April 11, 2019 (HealthDay News) — One out of every three U.S. cancer patients uses alternative or complementary therapies, but many keep that info from their doctors, a new study finds. That’s a real concern, the study’s lead author said, especially when it comes to supplements and cancer radiation… Read More »
by Heidi Hall Finding gives boost to fighting through cell metabolism NASCAR has nothing on cancer cells when it comes to exploiting the power of drafting, letting someone else do the hard work of moving forward while you coast behind. Building on the relatively new discovery that metastatic cancer cells leave tumors and travel in clusters,… Read More »
Anne Trafton | MIT News Office One of the most common cancer-promoting genes, known as Myc, is also one of the most difficult to target with drugs. Scientists have long tried to develop drugs that block the Myc protein, but so far their efforts have not been successful. Now, using an alternative strategy, MIT researchers… Read More »
The NHS in England has now missed its flagship cancer target for more than 1,000 days with one in four patients facing delays getting treatment. Hospitals are meant to start treatment within 62 days of a GP referral – and have been set a target of achieving that for 85% of patients. But latest figures,… Read More »